University patenting and licensing practices in the United Kingdom during the first year of the COVID-19 pandemic
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
-
SciScore for 10.1101/2021.09.20.21263777: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:However, engaging with FOIs as a research method has limitations, as public institutions are allowed to refuse requests under section 43(2) of The Act if “its disclosure under this Act would, or would be likely to, prejudice the commercial interests of any …
SciScore for 10.1101/2021.09.20.21263777: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:However, engaging with FOIs as a research method has limitations, as public institutions are allowed to refuse requests under section 43(2) of The Act if “its disclosure under this Act would, or would be likely to, prejudice the commercial interests of any person (including the public authority holding it)” (Freedom of Information Act 2000, 2000). This exemption based on commercial interests is sometimes employed by public research institutions to justify non-disclosure of information regarding the commercialisation of health technologies, as it is deemed commercially sensitive, but also in other cases such as the refusal to disclose clinical trial transparency policies (University of Liverpool, 2020). In the case of this particular study, the University of Oxford stated that disclosure would weaken the bargaining position of the OUI/University in the future (Supplementary 2). Oxford furthermore said that the university “recognises that there is some public interest in disclosure of the information (⃛) However (…) in common with the rest of the Higher Education sector, the University is under financial pressure. It cannot rely solely on public funds to finance improvements to teaching and research, and related activities. There is therefore a strong public interest that the University should be able to supplement its public funding by entering into mutually beneficial partnerships with the private sector, which will further its charitable objectives. Any disclosure that jeopa...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-